Search Results for keywords:"veterinary medicine"

Found 2 results
Skip to main content

Search Results: keywords:"veterinary medicine"

  • Type:Notice
    Citation:89 FR 96263
    Reading Time:about 5 minutes

    The Food and Drug Administration (FDA) has released a draft guideline titled “Evaluating Target Animal Safety and Effectiveness of Antibacterial New Animal Drugs for Bovine Mastitis,” now available for public comment. This guideline offers recommendations for medications that treat bovine mastitis through antibacterial agents administrable by intramammary infusion, but it might also be applicable to other forms or technologies. Individuals are encouraged to provide feedback until February 3, 2025. The document does not establish legal standards but reflects the current FDA views on the topic.

    Simple Explanation

    The FDA wants to hear what people think about a new set of advice for making safe and effective medicine for cows with a sickness called mastitis. This advice helps doctors pick the right medicine, but it's not like a strict rule, and everyone can share their thoughts about it until February 2025.

  • Type:Rule
    Citation:89 FR 95101
    Reading Time:about 7 minutes

    The Food and Drug Administration (FDA) has made changes to rules about animal drugs to update new and existing drug applications, improve readability, and ensure accurate information. These updates reflect approvals, withdrawals, and sponsorship changes for animal drugs from July to September 2024. The FDA also amended its regulations to communicate these changes and to clarify the information about sponsors and conditions of use for drugs. This rule is effective as of December 2, 2024.

    Simple Explanation

    The FDA updated the rules about animal medicines to make sure everything is clear and correct, like giving new permissions or changing who is in charge of the medicines.